Related Experiment Video

Updated: May 13, 2025

Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation
09:19

Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation

Published on: December 8, 2017

14.4K

Editorial: Targeting neuroinflammation for novel therapeutics in neurodegenerative diseases

Pukar Khanal1, Rupesh Chikhale2, Jatin Machhi3

  • 1Emory University, Atlanta, GA, United States.

Frontiers in Pharmacology
|May 12, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Alzheimer’s diseaseAmyotrophic Lateral SclerosisParkinson’s diseasecomputational pharmacologyethnopharmacologynanoengineering

More Related Videos

Targeted Neuronal Injury for the Non-Invasive Disconnection of Brain Circuitry10:58

Targeted Neuronal Injury for the Non-Invasive Disconnection of Brain Circuitry

Published on: September 27, 2020

5.1K
Novel Passive Clearing Methods for the Rapid Production of Optical Transparency in Whole CNS Tissue06:14

Novel Passive Clearing Methods for the Rapid Production of Optical Transparency in Whole CNS Tissue

Published on: May 8, 2018

8.7K

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
128